July 2, 2010
Shanghai, China
Finnegan partners Rich Racine, Esther Lim, and Ningling Wang will present on "Preparing and Prosecuting U.S. Patent Applications to Obtain USFDA Orange Book Listed Patents," "Surviving Bilski: Strategies for Biopharm Companies," and "Recent Developments of Biosimilars in the U.S.," at the Advanced Intellectual Property Seminar Series on "U.S. Patent Litigation for Chinese Companies." The seminar will take place at the Shangri-la Pudong in Shanghai, China. To register, please send an email to ipeventshanghai@finnegan.com.
Conference
Best Practices in Intellectual Property– A Decade of Dedication to IP Excellence
April 8-9, 2024
Tel Aviv
Lecture
IP (Intellectual Property) Due Diligence & Freedom to Operate in Practice Training Course
March 7-8, 2024
Virtual
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.